GSK press releases Follow GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding Following Pfizer’s exit, Shionogi’s holding increases to 21.7%, with GSK maintaining 78.3% majority share. https://www.gsk.com/en-gb/media/press-releases/gsk-pfizer-and-shionogi-agree-on-changes-to-viiv-healthcare-shareholding/ gsk.com
